N-乙基-1-苯基-1-乙胺 | 10137-87-8

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: N-乙基-1-苯基-1-乙胺
• 中文别名: N-乙基-1-苯基乙胺
• 英文名称: D(+)-N-Ethyl-N-(α-phenylethyl)-amin
• 英文别名: N-ethyl-1-phenylethanamine
• CAS: 10137-87-8
• 化学式: C₁₀H₁₅N
• mdl: MFCD00463430
• 分子量: 149.236
• InChiKey: GJKPTDGTWOVONJ-UHFFFAOYSA-N

物化性质

• 熔点：
  143°C (estimate)
• 沸点：
  230.33°C (estimate)
• 密度：
  0.9285 (estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2921499090

反应信息

• 作为反应物：
  描述：

  methyl(phenyl)hydroxymethylphosphine 、 N-乙基-1-苯基-1-乙胺 以 乙腈 为溶剂， 以70%的产率得到Ethyl-[(methyl-phenyl-phosphanyl)-methyl]-(1-phenyl-ethyl)-amine
  参考文献：
  名称：

  Chirale aminomethyl-phosphine und aminomethyl-diphosphine

  摘要：

  DOI：

  10.1016/s0040-4039(00)92795-3
• 作为产物：
  描述：

  氯苯 、 二乙胺 生成 N-乙基-1-苯基-1-乙胺
  参考文献：
  名称：

  GILBERT A.; KRESTONISICH S.; WESTOVER D. L., J. CHEM. SOC. PERKIN TRANS., PART 1, 1981, NO 1, 295-302

  摘要：

  DOI：

文献信息

• COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 POLYPEPTIDES
  申请人：Arvinas, Inc.

  公开号：US20190151295A1

  公开（公告）日：2019-05-23

  The present disclosure relates to bifunctional compounds, which find utility as modulators of Interleukin-1 Receptor-Associated Kinase 4 (IRAK-4); the target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a Von Hppel-Lindau, cereblon, ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

  本公开涉及双功能化合物，其作为白细胞介素-1受体相关激酶4（IRAK-4；目标蛋白）的调节剂具有实用性。具体而言，本公开涉及包含一端结合E3泛素连接酶的Von Hppel-Lindau、cereblon配体的双功能化合物，另一端结合目标蛋白的部分，使得目标蛋白靠近泛素连接酶以实现目标蛋白的降解（和抑制）。本公开展示了与目标蛋白的降解/抑制相关的广泛药理活性。本公开的化合物和组合物用于治疗或预防由目标蛋白聚集或积累导致的疾病或紊乱。
• [EN] BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS D'ALCYNES BICYCLIQUES ET LEURS UTILISATIONS
  申请人：AGENCY SCIENCE TECH & RES

  公开号：WO2015050505A1

  公开（公告）日：2015-04-09

  The present invention relates to certain compounds (e.g., imidazopyrazine, imidazopyridine, imidazopyridazine and imidazpyrimidine compounds) that act as inhibitors of the MAP kinase interacting kinases MNK2a, MNK2b, MNK1a, and MNK1b. The present invention further relates to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the prevention and treatment of diseases (e.g., proliferative diseases (e.g., cancer), inflammatory diseases, autoimmune diseases, metabolic diseases, and neurodegenerative diseases (e.g. autism, autism spectrum disorders, Alzheimer's disease)), as well as methods of treating these diseases

  本发明涉及某些化合物（例如，咪唑吡嗪、咪唑吡啶、咪唑吡嗪和咪唑嘧啶化合物），这些化合物作为MAP激酶相互作用激酶MNK2a、MNK2b、MNK1a和MNK1b的抑制剂。本发明还涉及包含这些化合物的药物组合物，以及利用这些化合物预防和治疗疾病（例如，增殖性疾病（例如癌症）、炎症性疾病、自身免疫性疾病、代谢性疾病和神经退行性疾病（例如自闭症、自闭症谱系障碍、阿尔茨海默病））的用途，以及治疗这些疾病的方法。
• [EN] BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS<br/>[FR] AGENTS THÉRAPEUTIQUES - 802
  申请人：ASTRAZENECA AB

  公开号：WO2009047558A1

  公开（公告）日：2009-04-16

  A compound of formula (I) or a pharmaceutically acceptable salt thereof in which R1, R2 , R3, R4 and m are as described in the specification for use in the treatment of obesity and/or diabetes.

  化合物的分子式（I）或其药用盐，其中R1、R2、R3、R4和m如说明书中所述，用于治疗肥胖和/或糖尿病。
• PROCESS FOR PRODUCING 1-SUBSTITUTED TRANS-4-(SUBSTITUTED AMINO) PIPERIDIN-3-OL
  申请人：Aikawa Toshiaki

  公开号：US20110172431A1

  公开（公告）日：2011-07-14

  A process is provided for producing a 1-substituted trans-4-(substituted amino)piperidin-3-ol represented by formula (III-1): The process includes a step of reacting a 1-substituted-3,4-epoxypiperidine represented by formula (I): with an amine compound represented by formula (II) in the presence of an inorganic lithium salt. By utilizing the process, trans-4-aminopiperidin-3-ol compounds useful as various chemical products, such as medicine intermediates, can be produced.

  提供了一种生产1-取代的反式-4-(取代氨基)哌啶-3-醇的过程，其化学式为(III-1)：该过程包括以下步骤：将一种化学式为(I)的1-取代-3,4-环氧哌啶与一种化学式为(II)的胺化合物在无机锂盐存在下反应。通过利用该过程，可以生产用途广泛的反式-4-氨基哌啶-3-醇化合物，如药物中间体等化学产品。
• [EN] CHIRALITY SENSING WITH MOLECULAR CLICK CHEMISTRY PROBES<br/>[FR] DÉTECTION DE CHIRALITÉ AVEC DES SONDES DE CHIMIE CLICK MOLÉCULAIRE
  申请人：UNIV GEORGETOWN

  公开号：WO2020028396A1

  公开（公告）日：2020-02-06

  The present invention relates to an analytical method that includes providing a sample potentially containing a chiral analyte that can exist in stereoisomeric forms, and providing a probe selected from the group consisting of coumarin-derived Michael acceptors, dinitrofluoroarenes and analogs thereof, arylsulfonyl chlorides and analogs thereof, arylchlorophosphines and analogs thereof, aryl halophosphites, and halodiazaphosphites. The sample is contacted with the probe under conditions to permit covalent binding of the probe to the analyte, if present in the sample; and, based on any binding that occurs, the absolute configuration of the analyte in the sample, and/or the concentration of the analyte in the sample, and/or the enantiomeric composition of the analyte in the sample is/are determined. The probe may be a coumarin-derived Michael acceptor, a di nitrofluoroarene or analog thereof, an arylsulfonyl chloride or analog thereof, an arylchlorophosphine or analog thereof, an aryl halophosphite, or a halodiazaphosphite.

  本发明涉及一种分析方法，包括提供一个潜在含有手性分析物的样品，该手性分析物可以存在于立体异构体形式中，并提供从香豆素衍生的Michael受体、二硝基氟芳烃及其类似物、芳基磺酰氯及其类似物、芳基氯代膦及其类似物、芳基卤代膦酸酯和卤代二氮磷酸酯组成的探针中选取的探针。将样品与探针在条件下接触，以允许探针与分析物共价结合，如果样品中存在分析物；基于发生的任何结合，确定样品中分析物的绝对构型，和/或样品中分析物的浓度，和/或样品中分析物的对映体组成。探针可以是香豆素衍生的Michael受体、二硝基氟芳烃或其类似物、芳基磺酰氯或其类似物、芳基氯代膦或其类似物、芳基卤代膦酸酯，或卤代二氮磷酸酯。